Abstract:Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism. The genetic defect in WD affects the ATP7B gene, which encodes the ATP7B transmembrane protein, which is essential for maintaining normal copper homeostasis in the body. It is primarily expressed in the liver and acts by incorporating copper into ceruloplasmin (Cp), the major copper transport protein in the blood. In conditions of excess copper, ATP7B transports it to bile for excretion. Mutations in ATP7B lead to impaired ATP7B function, resulting in copper accumulation in hepatocytes leading to their damage. The toxic "free"—unbound to Cp—copper released from hepatocytes then accumulates in various organs, contributing to their damage and clinical manifestations of WD, including hepatic, neurological, hematological, renal, musculoskeletal, ophthalmological, psychiatric, and other effects. While most clinical manifestations of WD correspond to identifiable organic or cellular damage, the pathophysiology underlying its psychiatric manifestations remains less clearly understood. A search for relevant articles was conducted in PubMed/Medline, Science Direct, Scopus, Willy Online Library, and Google Scholar, combining free text and MeSH terms using a wide range of synonyms and related terms, including "Wilson's disease", "hepatolenticular degeneration", "psychiatric manifestations", "molecular mechanisms", "pathomechanism", and others, as well as their combinations. Psychiatric symptoms of WD include cognitive disorders, personality and behavioral disorders, mood disorders, psychosis, and other mental disorders. They are not strictly related to the location of brain damage, therefore, the question arises whether these symptoms are caused by WD or are simply a coincidence or a reaction to the diagnosis of a genetic disease. Hypotheses regarding the etiology of psychiatric symptoms of WD suggest a variety of molecular mechanisms, including copper-induced CNS toxicity, oxidative stress, mitochondrial dysfunction, mitophagy, cuproptosis, ferroptosis, dysregulation of neurotransmission, deficiencies of neurotrophic factors, or immune dysregulation. New studies on the expression of noncoding RNA in WD are beginning to shed light on potential molecular pathways involved in psychiatric symptomatology. However, current evidence is still insufficient to definitively establish the cause of psychiatric symptoms in WD. It is possible that the etiology of psychiatric symptoms varies among individuals, with multiple biological and psychological mechanisms contributing to them simultaneously. Future studies with larger samples and comprehensive analyses are necessary to elucidate the mechanisms underlying the psychiatric manifestations of WD and to optimize diagnostics and therapeutic approaches.

Does Gut Microbiome have an Effect on Wilson’s Disease Phenotype?

Multi-omics study unravels gut microbiota and metabolites alteration in patients with Wilson's disease

Exploring the impact of gut microbiota on liver health in mice and patients with Wilson disease

Population Screening and Diagnostic Strategies in Screening Family Members of Wilson’s Disease Patients

Role of Gender and Age in Features of Wilson's Disease

Nutritional Status and Body Composition in Wilson Disease: A Cross-Sectional Study from China

Wilson Disease: Identification of Two Novel Mutations and Clinical Correlation in Eastern Chinese Patients

Metabolomic Profiling of Wilson Disease, an Inherited Disorder of Copper Metabolism, and Diseases with Similar Symptoms but Normal Copper Metabolism

Metabolomic and biochemical changes in the plasma and liver of toxic milk mice model of Wilson disease

Exploration of TCM syndrome types of the material basis and risk prediction of Wilson disease liver fibrosis based on 1H NMR metabolomics

Currently Clinical Views On Genetics Of Wilson'S Disease

Management Perspective of Wilsons Disease: Early Diagnosis and Individualized Therapy

Genetic Research Advances of Wilson Disease

Identification of potential modifier genes in Chinese patients with Wilson disease

Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism.

Psychiatric Symptoms in Wilson's Disease—Consequence of ATP7B Gene Mutations or Just Coincidence?—Possible Causal Cascades and Molecular Pathways

Wilson’s Disease in China

HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.

Copper impairs the intestinal barrier integrity in Wilson disease

Wilson’s disease: Update on integrated Chinese and Western medicine

Phenotypic and genetic characterization of children with Wilson Disease from Northeast China